» Articles » PMID: 26479996

Which Variables Are Useful for Predicting Severe Infection in Children With Febrile Neutropenia?

Overview
Specialty Pediatrics
Date 2015 Oct 20
PMID 26479996
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

To distinguish children with chemotherapy-induced febrile neutropenia (FN) at low risk of severe infection, the variables that are significant risk factors must be identified. Our objective was to identify them by applying evidence-based standards. This retrospective 2-center cohort study included all episodes of chemotherapy-induced FN in children in 2005 and 2006. The medical history, clinical, and laboratory data available at admission were collected. Severe infection was defined by bacteremia, a positive culture of a normally sterile body fluid, invasive fungal infection, or localized infection at high risk of extension. Univariate analysis identified potential predictive variables. A generalized mixed model was used to determine the adjusted variables that predict severe infection. We analyzed 372 FN episodes. Severe infections occurred in 16.1% of them. Variables predictive of severe infection at admission were: disease with high risk of prolonged neutropenia (adjusted odds ratio [aOR]=2.5), blood cancer (aOR=1.9), fever ≥38.5°C (aOR=3.7), and C-reactive protein level ≥90 mg/L (aOR=4.5). Now that we have identified these variables significantly associated with the risk of severe infection, they must be validated prospectively before combining the best predictive variables in a decision rule that can be used to distinguish children at low risk.

Citing Articles

Comprehensive Care Improvement for Oncologic Fever and Neutropenia from a Pediatric Emergency Department.

Kuehnel N, McCreary E, Henderson S, Vanderloo J, Hoover-Regan M, Sharp B Pediatr Qual Saf. 2024; 6(2):e390.

PMID: 38571520 PMC: 10990408. DOI: 10.1097/pq9.0000000000000390.


Omicron variant of SARS-CoV-2, an epidemiologic assessment of pediatric oncology patients in the Bronx.

Offenbacher R, Gorlick J, Weiser D Cancer Rep (Hoboken). 2022; 5(11):e1724.

PMID: 36199156 PMC: 9675379. DOI: 10.1002/cnr2.1724.


Biomarkers for Diagnosing Febrile Illness in Immunocompromised Children: A Systematic Review of the Literature.

van der Velden F, Gennery A, Emonts M Front Pediatr. 2022; 10:828569.

PMID: 35372147 PMC: 8965604. DOI: 10.3389/fped.2022.828569.


Risk stratification in children with cancer and febrile neutropenia: A national, prospective, multicentre validation of nine clinical decision rules.

Haeusler G, Thursky K, Slavin M, Babl F, De Abreu Lourenco R, Allaway Z EClinicalMedicine. 2020; 18:100220.

PMID: 31993576 PMC: 6978200. DOI: 10.1016/j.eclinm.2019.11.013.


Risk factors for bacteremia in children with febrile neutropenia.

Kara S, Tezer H, Polat M, Yayla B, Demirdag T, Okur A Turk J Med Sci. 2019; 49(4):1198-1205.

PMID: 31385488 PMC: 7018307. DOI: 10.3906/sag-1901-90.